首页> Movement disorders : official journal of the Movement Disorder Society> In Vivo Mapping of Catecholaminergic Loss and Iron Deposition in Huntington's Disease.

In Vivo Mapping of Catecholaminergic Loss and Iron Deposition in Huntington's Disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： Edoardo R,de Natale

第一单位： Neurodegeneration Imaging Group, University of Exeter Medical School, London, UK.

作者： Edoardo R,de Natale ^[1] ; Heather,Wilson ^[1] ; Efstratios,Karavasilis ^[2] ; Athanasia,Liozidou ^[3] ; Chrisoula,Kartanou ^[3] ; Georgios,Velonakis ^[2] ; Jens,Kuhle ^[4] ; Ioannis,Zalonis ^[3] ; Georgia,Karadima ^[3] ; Leonidas,Stefanis ^[3] ; Georgios,Koutsis ^[3] ; Marios,Politis ^[5]

作者单位： Neurodegeneration Imaging Group, University of Exeter Medical School, London, UK. ^[1] Research Unit of Radiology and Medical Imaging, 2nd Department of Radiology, Attikon General University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. ^[2] 1st Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Aiginition Hospital, Athens, Greece. ^[3] Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland. ^[4] Neurodegeneration Imaging Group, University of Exeter Medical School, London, UK.;1st Department of Neurology, School of Medicine, National and Kapodistrian University of Athens, Aiginition Hospital, Athens, Greece. ^[5]

关键词 Huntington's disease magnetic resonance imaging neurodegeneration neuromelanin quantitative susceptibility mapping

DOI 10.1002/mds.70221

PMID 41674446

发布时间 2026-02-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交